Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
Anne-Sophie MichalletArnaud CampidelliHelene LequeuMarie-Sarah DilhuydyOlivier TournilhacLuc-Matthieu ForneckerJehan DupuisFlorence CymbalistaSophie De GuibertAlain DelmerJean-Pierre VilqueDavid GhezVeronique LeblondFabien SubtilPierre FeugierLoic YsebaertPublished in: American journal of hematology (2017)